Exercise-induced Changes in Cardiac Function & Morphology

February 14, 2011 updated by: University Hospital Inselspital, Berne

Magnetic Resonance Technique in the Assessment of Exercise-induced Long- and Short-Term Changes in Cardiac Function and Morphology

Until now it has been assumed that regular endurance training has a positive influence on cardiac function and that the positive effect increases with increasing intensity. However, little is known about the effects of intense endurance stress on the heart. According to current knowledge repeated exposure to strenuous endurance activity may lead to minor but possibly irreversible damage to the heart with resultant scarring of the heart's muscle.

Within this study we attempt to find out by different analytical methods - in particular magnetic resonance imaging (MRI) and ultrasound of the heart - to what extent the heart muscle is affected by an intense endurance exercise, i.e. the "Jungfrau-Marathon", and which changes can possibly be found. Due to repeated measurements we will obtain further information on the short-term course of possible changes.

Hypotheses: A single bout of prolonged strenuous exercise (PSE) leads to transient alteration in cardiac function accompanied by the appearance of biomarkers for myocardial damage.

Study Overview

Detailed Description

Background

Despite the well documented cardio-protective effects of aerobic exercise of moderate intensity, short- and long-term consequences of strenuous exercise are less clear. There is increasing evidence that maintaining a high cardiac workload over a prolonged duration may result in transient impairment of cardiac function. Recent studies have also reported a transient increase in cardiac biomarkers after prolonged strenuous exercise. While in patients with cardiac disease the presence of cardiac dysfunction and increased cardiac biomarkers generally reflects myocardial damage, the impact of these observations in athletes is ill defined. It is a matter of concern whether in athletes such findings simply reflect a reversible response or whether repetitive events may lead to an accumulative cardiac damage. Traditional echocardiographic methods used to determine potential cardiac changes in morphology or function are investigator-dependent and may be subject to interference by cardiac pre- and afterload. Cardiac magnetic resonance imaging provides an investigator-independent and objective method to quantify cardiac dimensions and function. Delayed contrast enhancement MR imaging is a highly reproducible cardiovascular magnetic resonance imaging technique to directly visualize myocardial edema, necrosis and fibrosis.

Objective

To use cardiac and delayed contrast enhancement magnetic resonance imaging in combination with echocardiographic methods to quantify cardiac dysfunction after a single competitive PSE event and to study post-exercise changes in morphology and function as well as the post-exercise dynamics of specific markers of myocardial damage.

Methods

Cardiac and delayed contrast enhancement magnetic resonance imaging will be used in combination with echocardiographic methods to repetitively investigate post-exercise cardiac function and morphology in 10 elite athletes finishing the "Jungfrau Marathon". Biomarkers of myocardial damage are assessed simultaneously.

Post-exercise dynamics of the outcome parameters are followed over a minimum of 7 days after the exercise.

Study Type

Interventional

Enrollment (Actual)

11

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bern, Switzerland, CH-3010
        • Dept. of Diagnostic, Interventional and Pediatric Radiology, University Hospital Bern

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 38 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Participants of the Jungfraumarathon 2010
  • Elite runners defined by their results in the Jungfraumarathon 2009 (not more than 4:30 h, corresponding to a delay of 90 minutes compared to the winner)

Exclusion Criteria

  • Contraindication for MRI
  • • History of relevant cardiac disease (including cardiomyopathies)
  • coronary heart disease
  • coronary abnormalities
  • cardiovascular risk factors
  • History of any chronic disease
  • drug abuse

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 1
single event of a prolonged strenuous endurance exercise (mountain marathon)
"Jungfraumarathon": Mountain-Marathon with a length of 42km and a altitude-difference of approximately 1830meters.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Quantification of edema and/or ischemic areas with MRI
Time Frame: baseline
baseline
Quantification of edema and/or ischemic areas with MRI
Time Frame: 24h post-marathon
24h post-marathon
Quantification of edema and/or ischemic areas with MRI
Time Frame: 5 days post-marathon
5 days post-marathon
Quantification of edema and/or ischemic areas with MRI
Time Frame: 8 days post-marathon
8 days post-marathon

Secondary Outcome Measures

Outcome Measure
Time Frame
anthropometric data, VO2max, resting-ECG, stress-ECG, blood analyses
Time Frame: at baseline
at baseline
Cardiac contractility by echocardiography
Time Frame: 1h post-marathon
1h post-marathon
Cardiac contractility by echocardiography
Time Frame: 5 days post-marathon
5 days post-marathon
Cardiac contractility by echocardiography
Time Frame: 8 days post-marathon
8 days post-marathon
Cardiac contractility by echocardiography
Time Frame: baseline
baseline
various parameters of cardiac function and morphology assessed with MRI and echocardiography
Time Frame: baseline
baseline
various parameters of cardiac function and morphology assessed with MRI and echocardiography
Time Frame: 1h post-marathon
1h post-marathon
various parameters of cardiac function and morphology assessed with MRI and echocardiography
Time Frame: 1 day post-marathon
1 day post-marathon
various parameters of cardiac function and morphology assessed with MRI and echocardiography
Time Frame: 5 days post-marathon
5 days post-marathon
various parameters of cardiac function and morphology assessed with MRI and echocardiography
Time Frame: 8 days post-marathon
8 days post-marathon
Post-exercise levels and dynamics of blood parameters indicating cardiac damage, cardiac overload , inflammation and hormonal stress response
Time Frame: baseline
baseline
Post-exercise levels and dynamics of blood parameters indicating cardiac damage, cardiac overload , inflammation and hormonal stress response
Time Frame: 1h post-marathon
1h post-marathon
Post-exercise levels and dynamics of blood parameters indicating cardiac damage, cardiac overload , inflammation and hormonal stress response
Time Frame: 1 day post-marathon
1 day post-marathon
Post-exercise levels and dynamics of blood parameters indicating cardiac damage, cardiac overload , inflammation and hormonal stress response
Time Frame: 5 days post-marathon
5 days post-marathon
Post-exercise levels and dynamics of blood parameters indicating cardiac damage, cardiac overload , inflammation and hormonal stress response
Time Frame: 8 days post-marathon
8 days post-marathon

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Michael Ith, PhD, PhD/MD, Dept. of Diagnostic, Interventional and Pediatric Radiology, University Hospital Bern
  • Principal Investigator: Christoph Stettler, MD, Division of Endocrinology, Diabetes and Clinical Nutrition, University Hospital Bern

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2010

Primary Completion (Actual)

October 1, 2010

Study Completion (Actual)

October 1, 2010

Study Registration Dates

First Submitted

August 10, 2010

First Submitted That Met QC Criteria

August 10, 2010

First Posted (Estimate)

August 11, 2010

Study Record Updates

Last Update Posted (Estimate)

February 15, 2011

Last Update Submitted That Met QC Criteria

February 14, 2011

Last Verified

February 1, 2011

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myocardial Ischemia

Clinical Trials on Strenuous Endurance exercise

3
Subscribe